Annual Short Term Debt
$10.19 M
-$1.71 M-14.38%
31 December 2023
Summary:
Verve Therapeutics annual short term debt is currently $10.19 million, with the most recent change of -$1.71 million (-14.38%) on 31 December 2023. During the last 3 years, it has risen by +$10.19 million (+100.00%). VERV annual short term debt is now -14.38% below its all-time high of $11.90 million, reached on 31 December 2022.VERV Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$10.37 M
+$75.00 K+0.73%
30 September 2024
Summary:
Verve Therapeutics quarterly short term debt is currently $10.37 million, with the most recent change of +$75.00 thousand (+0.73%) on 30 September 2024. Over the past year, it has increased by +$250.00 thousand (+2.47%). VERV quarterly short term debt is now -12.90% below its all-time high of $11.90 million, reached on 31 December 2022.VERV Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.4% | +2.5% |
| 3 y3 years | +100.0% | +351.8% |
| 5 y5 years | - | - |
VERV Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.4% | -12.9% | +1043.1% | |
| 5 y | 5 years | -14.4% | -12.9% | ||
| alltime | all time | -14.4% | -12.9% |
Verve Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.37 M(+0.7%) |
| June 2024 | - | $10.29 M(+0.7%) |
| Mar 2024 | - | $10.22 M(+0.3%) |
| Dec 2023 | $10.19 M(-14.4%) | $10.19 M(+0.7%) |
| Sept 2023 | - | $10.12 M(+0.7%) |
| June 2023 | - | $10.05 M(-10.2%) |
| Mar 2023 | - | $11.18 M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $11.90 M(+508.9%) | $11.90 M(+33.7%) |
| Sept 2022 | - | $8.90 M(+881.7%) |
| June 2022 | - | $907.00 K(-36.7%) |
| Mar 2022 | - | $1.43 M(-26.8%) |
| Dec 2021 | $1.96 M(>+9900.0%) | $1.96 M(-14.8%) |
| Sept 2021 | - | $2.29 M(>+9900.0%) |
| Dec 2020 | $0.00 | - |
| Dec 2020 | - | $0.00 |
FAQ
- What is Verve Therapeutics annual short term debt?
- What is the all time high annual short term debt for Verve Therapeutics?
- What is Verve Therapeutics annual short term debt year-on-year change?
- What is Verve Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Verve Therapeutics?
- What is Verve Therapeutics quarterly short term debt year-on-year change?
What is Verve Therapeutics annual short term debt?
The current annual short term debt of VERV is $10.19 M
What is the all time high annual short term debt for Verve Therapeutics?
Verve Therapeutics all-time high annual short term debt is $11.90 M
What is Verve Therapeutics annual short term debt year-on-year change?
Over the past year, VERV annual short term debt has changed by -$1.71 M (-14.38%)
What is Verve Therapeutics quarterly short term debt?
The current quarterly short term debt of VERV is $10.37 M
What is the all time high quarterly short term debt for Verve Therapeutics?
Verve Therapeutics all-time high quarterly short term debt is $11.90 M
What is Verve Therapeutics quarterly short term debt year-on-year change?
Over the past year, VERV quarterly short term debt has changed by +$250.00 K (+2.47%)